Irinotecan: Summary and future directions

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)46-47
Number of pages2
JournalOncology
Volume15
Issue number1 SUPPL. 1
StatePublished - 2001

Fingerprint

irinotecan
Phytogenic Antineoplastic Agents
Camptothecin
Combined Modality Therapy
Small Cell Carcinoma
Survival Analysis
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Direction compound

ASJC Scopus subject areas

  • Oncology

Cite this

Irinotecan : Summary and future directions. / Johnson, David H.

In: Oncology, Vol. 15, No. 1 SUPPL. 1, 2001, p. 46-47.

Research output: Contribution to journalArticle

Johnson, DH 2001, 'Irinotecan: Summary and future directions', Oncology, vol. 15, no. 1 SUPPL. 1, pp. 46-47.
Johnson, David H. / Irinotecan : Summary and future directions. In: Oncology. 2001 ; Vol. 15, No. 1 SUPPL. 1. pp. 46-47.
@article{20b61d0834c446e4a31127039cbca011,
title = "Irinotecan: Summary and future directions",
author = "Johnson, {David H.}",
year = "2001",
language = "English (US)",
volume = "15",
pages = "46--47",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "1 SUPPL. 1",

}

TY - JOUR

T1 - Irinotecan

T2 - Summary and future directions

AU - Johnson, David H.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035236186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035236186&partnerID=8YFLogxK

M3 - Article

C2 - 11221021

AN - SCOPUS:0035236186

VL - 15

SP - 46

EP - 47

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 1 SUPPL. 1

ER -